CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale 10% owner sold 29,846 shares at $25.54 ($762,174)
- 4 Planned sale 10% owner sold 74,910 shares at an average $25.98 ($1,945,918)
- 4 Planned sale 10% owner sold 91,068 shares at an average $25.58 ($2,329,520)
- 4 Planned sale 10% owner sold 157,234 shares at an average $25.86 ($4,066,714)
- 4 Planned sale 10% owner sold 115,480 shares at an average $25.95 ($2,996,156)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Planned sale 10% owner sold 191,762 shares at an average $25.34 ($4,859,875)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 4 Planned sale 10% owner sold 462,288 shares at an average $25.40 ($11,740,618)
Page 10 of 21 · 415 filings